Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
Switzerland
Department of Visceral Surgery and Medicine, University Hospital Inselspital, Berne, Bern Last updated February 2026